Evidence map›Paper›PMID 29321143›Full record

ArticleJournal of the American Society of Nephrology : JASN2018

Control of Humoral Response in Renal Transplantation by Belatacept Depends on a Direct Effect on B Cells and Impaired T Follicular Helper-B Cell Crosstalk.

Claire Leibler, Allan Thiolat, Carole Hénique, Chloé Samson, Caroline Pilon, Marie Tamagne, France Pirenne, Benoit Vingert, José L Cohen, Philippe Grimbert

Registry-linked trialOpen access · greenAbstract read
In one paragraph

Article in Journal of the American Society of Nephrology : JASN, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT05145296 (Non-Randomized, Single-Center Pilot Trial Assessing The Safety/Efficacy Of Targeting Peripheral And Central Humoral Alloimmune Memory With Daratumumab And With Belatacept In Highly HLA-Sensitized Patients Awaiting Kidney Transplantation), which is not on this map. Cited by 58 papers.

0numbers the graph read from it
0cells of the map it votes in
58citing papers in PubMed
10.5field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05145296 phase2terminatednot on this mapstarted 2022, after this paper: background citation

Non-Randomized, Single-Center Pilot Trial Assessing The Safety/Efficacy Of Targeting Peripheral And Central Humoral Alloimmune Memory With Daratumumab And With Belatacept In Highly HLA-Sensitized Patients Awaiting Kidney Transplantation

TypeinterventionalSponsorUniversity Hospital, GrenobleRan2022 to 2025Enrolled5ConditionsSensitisation, Highly Sensitised Dialysis PatientsArmsEach patient will undergo in the first step of the study belatacept treatment and in the second apheresis and daratumumab
3 · Its place in the literature

Who cites it

58 citing papers in PubMed, 92 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. Review
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Claire LeiblerUniversité Paris-Est, Unité Mixte de Recherche 955, Université Paris-Est-Créteil, Creteil, France.
Allan ThiolatUniversité Paris-Est, Unité Mixte de Recherche 955, Université Paris-Est-Créteil, Creteil, France.
Carole HéniqueUniversité Paris-Est, Unité Mixte de Recherche 955, Université Paris-Est-Créteil, Creteil, France.
Chloé SamsonUniversité Paris-Est, Unité Mixte de Recherche 955, Université Paris-Est-Créteil, Creteil, France.
Caroline PilonUniversité Paris-Est, Unité Mixte de Recherche 955, Université Paris-Est-Créteil, Creteil, France.
Marie TamagneU955, Team 2, Institut National de la Santé et de la Recherche Médicale, Creteil, France.
France PirenneU955, Team 2, Institut National de la Santé et de la Recherche Médicale, Creteil, France.
Benoit VingertU955, Team 2, Institut National de la Santé et de la Recherche Médicale, Creteil, France.
José L CohenUniversité Paris-Est, Unité Mixte de Recherche 955, Université Paris-Est-Créteil, Creteil, France.
Philippe GrimbertUniversité Paris-Est, Unité Mixte de Recherche 955, Université Paris-Est-Créteil, Creteil, France; philippe.grimbert@aphp.fr.
Inserm · FRUniversité Paris-Est Créteil · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Generation of

Indexed as

AbataceptAgedAllograftsB7-2 AntigenB-LymphocytesCD28 AntigensCell CommunicationCell DifferentiationCells, CulturedCoculture TechniquesFemaleHumansImmunity, HumoralImmunoglobulin GImmunosuppressive AgentsKidney TransplantationAbataceptB7-2 AntigenCD28 AntigensCD86 protein, humanImmunoglobulin GImmunosuppressive AgentsPositive Regulatory Domain I-Binding Factor 1PRDM1 protein, humanSTAT3 protein, humanSTAT3 Transcription FactorB cellsBelatacept (CTLA4-Ig)kidney transplantationT follicular helper cells

Identifiers

PMID29321143
PMCPMC5827599
OpenAlexW2783160856

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.